Vilon, a synthetic dipeptide composed of lysine and glutamic acid (Lys-Glu), has emerged as a molecule of growing interest in the field of bioregulatory peptide research. Despite its minimal structure, Vilon is theorized to exert a wide range of biological supports, particularly in the domains of immunomodulation, gene expression regulation, and cellular aging. Originally developed by researchers at the St. Petersburg Institute of Bioregulation and Gerontology, Vilon belongs to a class of short peptides that are hypothesized to interact with chromatin and support gene transcription. Its simplicity, coupled with its…
Read MoreVilon Peptide: A Minimalist Bioregulator with Expansive Potential
